Proteostasis Therapeutics COM

Proteostasis Therapeutics COM is a security (CUSIP HB0000641) tracked across SEC portfolio filings. 1 institutional managers reported $30K on Form 13F as of 2026-03-31.

Summary

• Issuer: Proteostasis Therapeutics
• Class: COM
• CUSIP: HB0000641
• 13F holders: 1
• 13F value: $30K
• 13F period: 2026-03-31
• N-PORT fund positions: 0

Top institutional holders (Form 13F)

More

• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search